- Home
- IMOS vs ORGO Comparison
IMOS vs ORGO Comparison
Compare IMOS & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMOS
- ORGO
- Stock Information
- Founded
- IMOS 1997
- ORGO 1985
- Country
- IMOS Taiwan
- ORGO United States
- Employees
- IMOS N/A
- ORGO N/A
- Industry
- IMOS Semiconductors
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- IMOS Technology
- ORGO Health Care
- Exchange
- IMOS Nasdaq
- ORGO Nasdaq
- Market Cap
- IMOS 713.8M
- ORGO 620.3M
- IPO Year
- IMOS N/A
- ORGO N/A
- Fundamental
- Price
- IMOS $20.30
- ORGO $4.04
- Analyst Decision
- IMOS
- ORGO Buy
- Analyst Count
- IMOS 0
- ORGO 3
- Target Price
- IMOS N/A
- ORGO $7.33
- AVG Volume (30 Days)
- IMOS 10.8K
- ORGO 769.1K
- Earning Date
- IMOS 11-04-2025
- ORGO 11-06-2025
- Dividend Yield
- IMOS 3.15%
- ORGO N/A
- EPS Growth
- IMOS N/A
- ORGO N/A
- EPS
- IMOS 0.01
- ORGO N/A
- Revenue
- IMOS $777,452,000.00
- ORGO $429,531,000.00
- Revenue This Year
- IMOS $3.76
- ORGO $2.51
- Revenue Next Year
- IMOS $5.93
- ORGO $25.45
- P/E Ratio
- IMOS $119.37
- ORGO N/A
- Revenue Growth
- IMOS 0.89
- ORGO N/A
- 52 Week Low
- IMOS $12.78
- ORGO $2.61
- 52 Week High
- IMOS $22.79
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- IMOS 60.61
- ORGO 39.12
- Support Level
- IMOS $19.24
- ORGO $3.84
- Resistance Level
- IMOS $20.91
- ORGO $4.21
- Average True Range (ATR)
- IMOS 0.42
- ORGO 0.17
- MACD
- IMOS -0.10
- ORGO -0.01
- Stochastic Oscillator
- IMOS 66.11
- ORGO 33.04
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.